National Research Co. (NASDAQ:NRC) Major Shareholder Amandla Mk Trust Sells 2,600 Shares

National Research Co. (NASDAQ:NRC) major shareholder Amandla Mk Trust sold 2,600 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $64.01, for a total value of $166,426.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Amandla Mk Trust also recently made the following trade(s):

  • On Friday, November 29th, Amandla Mk Trust sold 4,853 shares of National Research stock. The shares were sold at an average price of $63.96, for a total value of $310,397.88.
  • On Monday, November 25th, Amandla Mk Trust sold 4,445 shares of National Research stock. The shares were sold at an average price of $63.95, for a total value of $284,257.75.
  • On Thursday, November 21st, Amandla Mk Trust sold 1,565 shares of National Research stock. The shares were sold at an average price of $63.81, for a total value of $99,862.65.
  • On Wednesday, September 18th, Amandla Mk Trust sold 500,000 shares of National Research stock. The shares were sold at an average price of $60.50, for a total value of $30,250,000.00.
  • On Tuesday, September 3rd, Amandla Mk Trust sold 33,800 shares of National Research stock. The shares were sold at an average price of $64.84, for a total value of $2,191,592.00.

Shares of NASDAQ NRC opened at $63.41 on Tuesday. The stock has a market cap of $1.61 billion, a price-to-earnings ratio of 60.97 and a beta of 0.79. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 1.07. National Research Co. has a 1-year low of $35.72 and a 1-year high of $68.86. The stock’s 50-day moving average is $59.93 and its 200 day moving average is $47.09.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.32%. This is a boost from National Research’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Monday, December 30th. National Research’s dividend payout ratio (DPR) is currently 73.08%.

Separately, ValuEngine cut National Research from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd.

Several hedge funds and other institutional investors have recently made changes to their positions in NRC. Bessemer Group Inc. raised its holdings in shares of National Research by 31.9% during the 2nd quarter. Bessemer Group Inc. now owns 62,410 shares of the company’s stock valued at $3,594,000 after buying an additional 15,100 shares in the last quarter. Bowling Portfolio Management LLC purchased a new position in National Research in the 2nd quarter worth approximately $668,000. Aperio Group LLC purchased a new position in National Research in the 2nd quarter worth approximately $176,000. Advisor Group Inc. increased its stake in National Research by 17.8% in the 2nd quarter. Advisor Group Inc. now owns 2,263 shares of the company’s stock worth $131,000 after purchasing an additional 342 shares during the period. Finally, Janus Henderson Group PLC purchased a new position in National Research in the 2nd quarter worth approximately $682,000. 39.67% of the stock is currently owned by institutional investors.

About National Research

National Research Corporation (NRC) is a provider of analytics and insights that facilitate revenue growth, patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. The Company’s portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

See Also: What are gap-down stocks?

Insider Buying and Selling by Quarter for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.